Disease: Focal segmental glomerulosclerosis
- A de novo novel variant in the MT-TD gene is associated with prominent extra-neurologic manifestations
- A family with neuronal intranuclear inclusion disease with focal segmental glomerulosclerosis
- A Novel <em>COL4A5</em> Pathogenic Variant Joins the Dots in a Family with a Synchronous Diagnosis of Alport Syndrome and Polycystic Kidney Disease
- A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury
- A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD/FSGS (TURING)
- A Review of Focal Segmental Glomerulosclerosis Classification With a Focus on Genetic Associations
- A Small Molecule Agonist of Krüppel-Like Factor 15 in Proteinuric Kidney Disease
- Adhesion G Protein-Coupled Receptor <em>Gpr126</em> (<em>Adgrg6</em>) Expression Profiling in Diseased Mouse, Rat, and Human Kidneys
- Advances in primary glomerulonephritis
- An unusual case of nephrotic syndrome
- An Update on Viral Infection-Associated Collapsing Glomerulopathy
- Angiotensin II Type 2 Receptor Antibodies in Glomerular Diseases
- Association of Obesity With Kidney and Cardiac Outcomes Among Patients With Glomerular Disease: Findings From the Cure Glomerulonephropathy Network
- Author Correction: A new index for the outcome of focal segmental glomerulosclerosis
- Autoantibodies Targeting Nephrin in Podocytopathies
- C4d expression in focal segmental glomerulosclerosis
- Canonical effects of cytokines on glomerulonephritis: A new outlook in nephrology
- Cardiovascular, Kidney Failure, and All-Cause Mortality Events in Patients with Focal Segmental Glomerulosclerosis in a U.S. Real-World Database
- Cathepsin S (CTSS) in IgA nephropathy: an exploratory study on its role as a potential diagnostic biomarker and therapeutic target
- Caught by Surprise - Microfilaria in Renal Biopsies
- Changes in the spectrum of biopsy-proven renal diseases over 11 years: a single-center study in China
- Characterization of renal damage in Wilson's disease-Detailed analysis of 20 Chinese cases
- Clinical and genetic analysis of a child with Focal segmental glomerulosclerosis due to a novel variant of PLCE1 gene
- Clinical characteristics and favorable treatment responses of recurrent focal segmental glomerulosclerosis or steroid-resistant nephrotic syndrome in children after kidney transplantation
- Clinical Course of Nonresponders With Recurrent Focal Segmental Glomerulosclerosis After Pediatric Kidney Transplantation: A Retrospective Multicenter Study
- Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series
- Clinical Relevance of Computationally Derived Tubular Features: Spatial Relationships and the Development of Tubulointerstitial Scarring in MCD/FSGS
- Collapsing Glomerulopathy
- Combined Rituximab and Daratumumab Treatment in Difficult-to-Treat Nephrotic Syndrome Cases
- Contemporary Immunosuppression Management and 1-Year Outcomes in Dual Organ Heart Transplantation
- Dach1 is essential for maintaining normal mature podocytes
- De Novo Biopsy-Proven Glomerular Disease Following COVID-19 Vaccination
- Deletion of NuRD component <em>Mta2</em> in nephron progenitor cells causes developmentally programmed FSGS
- Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial
- Design of a User-Centered Electronic Health Tool for Glomerular Disease Management
- Developmental Causes of Focal Segmental Glomerulosclerosis
- Differentiated metabolomic profiling reveals plasma amino acid signatures for primary glomerular disease
- Discovery of pyridazinone derivatives bearing tetrahydroimidazo[1,2-a]pyrazine scaffold as potent inhibitors of transient receptor potential canonical 5 to ameliorate hypertension-induced renal injury in rats
- Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter Study
- Efficacy and safety of dapagliflozin in children with kidney disease: real-world data
- Evaluation of pathogenicity of WT1 intron variants by in vitro splicing analysis
- Five-Year study on renal outcomes in biopsy-proven focal segmental glomerulosclerosis patients in Shiraz, Iran
- Focal Segmental Glomerulosclerosis
- Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study
- Genetic Causes of Nephrotic Syndrome and Focal and Segmental Glomerulosclerosis
- Genome editing and kidney health
- Glomerular basement membrane ultrastructural changes in a patient with COQ2 glomerulopathy: A case report
- Homozygosity for a Rare FASTKD2 Variant Resulting in an Adult Onset Autosomal Recessive Mitochondrial Podocytopathy
- Identification of Pathogenic Pathways for Recurrence of Focal Segmental Glomerulosclerosis after Kidney Transplantation
- Idiopathic membranous nephropathy with focal segmental sclerosis
- INF2 formin variants linked to human inherited kidney disease reprogram the transcriptome, causing mitotic chaos and cell death
- Investigating FSGS-like injury in zebrafish larvae by nifurpirinol: efficacy and molecular insight
- Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort
- Management of focal segmental glomerulosclerosis in resource-limited regions
- Mechanism of protective actions of sparsentan in the kidney: lessons from studies in models of chronic kidney disease
- Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS) are a Spectrum of a Single Disease Within Immune-Mediated Nephrotic Syndrome
- miR-196a in the carcinogenesis and other disorders with an especial focus on its biomarker capacity
- Missense Mutant Gain-of-Function Causes Inverted Formin 2 (INF2)-Related Focal Segmental Glomerulosclerosis (FSGS)
- Multiple-target Therapy for Posttransplant Focal Segmental Glomerulosclerosis
- MYH9-related disorder with sole presentation of end-stage kidney disease and long-term, recurrence-free living after living donor renal transplantation: a case report
- National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) study
- Nephrotic Syndrome Throughout Childhood: Diagnosing Podocytopathies From the Womb to the Dorm
- Novel mutation patterns in children with steroid-resistant nephrotic syndrome
- Outcome of Glomerular Disease Manifesting After Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2
- Paraneoplastic glomerulonephritis and kidney infiltration by mantle cell lymphoma: A diagnostic challenge
- Patterns of coronary artery disease trends in patients with nephrotic syndrome: A national inpatient study
- Podocyte density as a predictor of long-term kidney outcome in obesity-related glomerulopathy
- Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us?
- Podocytopathies associated with familial partial lipodystrophy due to LMNA variants: report of two cases
- Potential biomarkers of recurrent FSGS: a review
- Pre-transplant Anti-Nephrin Antibodies are Specific Predictors of Recurrent Diffuse Podocytopathy in the Kidney Allograft
- Pregnancy outcome in a patient with end-stage kidney disease treated with an intensive automated peritoneal dialysis regimen: A case report
- Primary focal segmental glomerulosclerosis in a patient with ankylosing spondylitis: A rare presentation requiring a broad differential in nephrotic syndrome
- Prophylactic treatment of FSGS recurrence in patients who relapsed in a previous kidney graft
- Protective Role of the Podocyte IL-15 / STAT5 Pathway in Focal Segmental Glomerulosclerosis
- Relapse during and after regular single-dose rituximab treatment in adult patients with steroid-dependent nephrotic syndrome
- Renal and cardiac biopsy findings in an adolescent patient with the 3243A>G mitochondrial DNA mutation: Favorable renal prognosis post renal transplantation from the mother
- Renal and Urinary Conditions: Nephrotic Syndrome
- Rescue with obinutuzumab and daratumumab as combined B cell/plasma cell targeting approach in severe posttransplant focal segmental glomerulosclerosis recurrence
- Rescue with Obinutuzumab and Daratumumab as Combined B-cell/Plasma Cell Targeting Approach in Severe Post-Transplant FSGS Recurrence
- Risk factors for acute kidney injury and kidney relapse in patients with lupus podocytopathy
- Rituximab in Steroid-Dependent Podocytopathies
- Role of Podocyte in Kidney Disease
- Role of TSP-1 and its receptor ITGB3 in the renal tubulointerstitial injury of focal segmental glomerulosclerosis
- Safety and Biodistribution of an Autologous Bone Marrow-Derived Mononuclear Cell Infusion into Renal Arteries in Patients with Focal Segmental Glomerulosclerosis: A Phase 1 Study
- Sparsentan for Focal Segmental Glomerulosclerosis in the DUET Open-Label Extension: Long-term Efficacy and Safety
- Spectrum of Kidney Biopsy Findings Associated With Methamphetamine Use
- Spectrum of non-diabetic kidney diseases in patients with type 2 DM who underwent kidney biopsy in Egypt
- Spectrum of Nondiabetic Kidney Diseases in Patients with Type 2 Diabetes Mellitus Who Underwent Kidney Biopsy in Egypt
- The Lectin Pathway-A Dominant Pattern of the Complement System Activation in Primary Focal Segmental Glomerulosclerosis?
- The Prevalence and Clinicopathological Spectrum of Nondiabetic Renal Disease in Patients with Diabetes in a Tertiary Care Center
- The Pursuit of New Treatments for Focal Segmental Glomerulosclerosis: Harmonizing Innovation With the DUET Study of Sparsentan
- The Sensitivity and Specificity of Serum Phospholipase A2 Receptor Antibodies in Diagnosing Primary Membranous Nephropathy in Patients with Adult Nephrotic Syndrome and its Correlation with Serum Phospholipase A2 Receptor Staining in Kidney Biopsies
- The significance of subclassifying focal segmental glomerulosclerosis lesions (S1) in IgA nephropathy
- Tmem30a protects against podocyte injury through suppression of pyroptosis
- Townes-Brocks Syndrome Revealed by Kidney Gene Panel Testing
- TRPC6 is ubiquitously present in lymphatic tissues: A study using samples from body donors
- Unmasking Focal Segmental Glomerulosclerosis in a Patient With Lupus Nephritis
- Unraveling the Role of Complement in Focal Segmental Glomerulosclerosis Pathogenesis: Insights and Challenges
- Variant upon variant: kidney-disease risk associated with APOL1 G2 genetic variants is abrogated by the APOL1 p.N264K variant